Brian Bettencourt, PhDSenior Vice President, Research at Triplet Therapeutics, Inc
Brian joined Triplet Therapeutics, Inc. in 2018 and serves as Senior Vice President of Research, heading up the Computational and Cellular/Molecular Biology groups. Brian has held various leadership roles in industry, including most recently leading the Bioinformatics group at Translate Bio. He led the development of siRNA efficacy prediction in Bioinformatics and founded the Biometrics department at Alnylam Pharmaceuticals. Prior to moving to industry, Brian was a professor in Biology at the University of Massachusetts Lowell with a research focus on Drosophila models of triplet expansion.